Device and method for treating the anal sphincter
AssigneeRDD Pharma Ltd.
InventorNir Barak
Life of this patent
Estimating the term…
Abstract
A rectally insertable device for localized drug delivery to the anal sphincter of a subject, a method of using the device and the use of the device is disclosed. The device comprises a shell for containing an active pharmaceutical ingredient, the shell being substantially impermeable to the active pharmaceutical ingredient wherein a lower portion of the shell is configured to release the active pharmaceutical ingredient from the shell and wherein when the device is inserted into the rectum of the subject, the lower portion of the shell is proximal to the anal sphincter, such that the active pharmaceutical ingredient is released proximal to the anal sphincter.
Claims16
A drug delivery device comprising:
- a shell sized for insertion in a rectum of a subject and which comprises within the shell a pharmaceutical composition,
- wherein the pharmaceutical composition comprises a pharmaceutically acceptable carrier and an active pharmaceutical ingredient,
- wherein the carrier is a solid at normal room temperature and has a melting point so as to melt due to a rectal temperature of the subject, and
- wherein the shell has an upper end and sides that are continuous, wherein the shell has a lower portion with an aperture, and wherein the upper end and sides are impermeable to the active pharmaceutical ingredient and impermeable to water;
- and
- a wick having a first portion extending from the inside of the shell and passing through the aperture of the shell, and a second portion positioned outside the shell, wherein:
- (i) the first portion is configured to contact the active pharmaceutical ingredient during delivery of the active pharmaceutical ingredient, and
- (ii) the second portion is positionable proximal to an anal sphincter upon insertion of the device into the rectum of the subject,
- wherein, when the device is inserted into the rectum of the subject, the carrier melts due to the rectal temperature of the subject, and the active pharmaceutical ingredient is released from the second portion of the wick proximal to the anal sphincter.
Dependencies are inferred from the claim text.